What is the maximum pediatric dose of amoxicillin‑clavulanate (Augmentin) for prophylaxis following a dog bite?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Maximum Pediatric Dose of Augmentin for Dog Bite Prophylaxis

For pediatric dog bite prophylaxis, the maximum dose of amoxicillin-clavulanate is 90 mg/kg/day of the amoxicillin component, divided into two doses (every 12 hours), not to exceed adult dosing. 1

Dosing Framework

Standard Prophylactic Dosing

The 2014 IDSA guidelines recommend amoxicillin-clavulanate as the first-line agent for animal bite prophylaxis 2. While the guidelines list adult dosing (875/125 mg twice daily), they do not specify exact pediatric prophylactic doses. However, the FDA-approved dosing provides clear parameters:

  • Standard formulations: 20-40 mg/kg/day of amoxicillin component in divided doses 3
  • High-dose formulation (ES-600): 90 mg/kg/day of amoxicillin component divided every 12 hours 1
  • Absolute maximum: Do not exceed adult doses regardless of weight 3

Practical Application by Clinical Scenario

For high-risk bites requiring prophylaxis (hand/face injuries, deep punctures, immunocompromised patients, wounds >9 hours old):

  • Children ≥3 months: Use 45 mg/kg/dose twice daily (90 mg/kg/day total) of the amoxicillin component 1
  • Children ≥40 kg: Use adult dosing of 875/125 mg twice daily 1
  • Duration: 3-5 days 2, 4

For standard-risk bites (if prophylaxis chosen):

  • 25-45 mg/kg/day divided twice or three times daily is appropriate 3, 5

Critical Dosing Considerations

Maximum Daily Limits

The ES-600 formulation explicitly states its maximum is 90 mg/kg/day of amoxicillin 1. This represents the upper boundary for pediatric dosing. Children weighing ≥40 kg should receive adult dosing rather than weight-based calculations that would exceed adult doses 1.

Formulation-Specific Warnings

Do not substitute formulations interchangeably - the ES-600 suspension contains 42.9 mg clavulanate per 5 mL, while standard 400 mg/5 mL contains 57 mg clavulanate per 5 mL 1. Using the wrong formulation can lead to under- or overdosing of the clavulanate component.

Evidence-Based Context

Recent pediatric studies show overall infection rates after dog bites are low (3-5.8%) regardless of antibiotic use 6, 7. The IDSA guidelines specifically recommend prophylaxis only for high-risk scenarios: immunocompromised patients, asplenic patients, advanced liver disease, significant edema, moderate-to-severe injuries (especially hand/face), or wounds penetrating periosteum/joint capsule 2, 4.

Key clinical pearl: Wounds presenting >9 hours after injury show significant benefit from prophylaxis (infection rate reduction, p=0.023), while wounds <9 hours show minimal benefit unless high-risk features present 8.

Administration Details

  • Timing: Give at start of meals to minimize GI intolerance and enhance clavulanate absorption 1
  • Storage: Reconstituted suspension stable 10 days refrigerated 1
  • Hepatic monitoring: Required in hepatically impaired patients 1

The maximum safe dose is clearly established at 90 mg/kg/day of the amoxicillin component, but clinical judgment should guide whether prophylaxis is indicated at all, given the low baseline infection rates in most pediatric dog bites.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.